Clinical Trials Directory

Trials / Unknown

UnknownNCT03287570

Efficacy and Safety of Cettum for Knee Osteoarthritis

Clinical Research on the Efficacy and Safety of Cettum on Knee Osteoarthritis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
138 (estimated)
Sponsor
Eun Jung Kim · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is verify the efficacy and safety of Cettum (Electric moxibustion) for patients with knee osteoarthritis.

Detailed description

The investigator targets the patients with knee osteoarthritis. After treatment in 3 groups - Cettum treatment, traditional indirect moxibustion treatment, and usual care groups - the investigators will compare the effects of pain relieving and daily performing improvement. So the investigators will confirm the efficacy of Cettum, and further the best treatment method. In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.

Conditions

Interventions

TypeNameDescription
DEVICECettumThe treatment is applied twice a week for 15 minutes for 6 weeks (12 sessions). 6 points (ST36, ST35, EX-LE4, SP9, SP10, ST34) are used for all the patients assigned to this group and investigator can be added up to 2 points depending on the patient condition. Electric moxibustion, Cettum (20X28X18mm) manufactured by K-medical Co.(Korea) is used.
PROCEDURETraditional indirect moxibustionThe treatment is applied twice a week for 6 weeks (12 sessions). 6 points (ST36, ST35, EX-LE4, SP9, SP10, ST34) are used for all the patients assigned to this group and investigator can be added up to 2 points depending on the patient condition. Traditional indirect moxibustion, Taekeukttum manufactured by Haenglim Seowon Medical Co.(China) is used. A total of three moxibustion cones are applied indirectly to each point per treatment session.
OTHERUsual careThe patients in this group maintain the usual treatment and self-care.

Timeline

Start date
2017-09-20
Primary completion
2018-08-01
Completion
2018-12-01
First posted
2017-09-19
Last updated
2017-10-19

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03287570. Inclusion in this directory is not an endorsement.